What is the Impact Factor of Hormones & Cancer?

The journal Hormones & Cancer is indexed in Web of Science (SCIE, quartile Q1) with official metrics continually updated on ImpaQ.

Is Hormones & Cancer indexed in Web of Science or Scopus?

Yes, Hormones & Cancer is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of N/A (Q1) and an H-index of 30.

Who publishes Hormones & Cancer and what is the Article Processing Charge (APC)?

Hormones & Cancer is published by Springer US. For exact article processing charges and subscription guidelines, consult the official editorial guidelines.

What is the ISO-4 abbreviation and acronym of Hormones & Cancer?

The official ISO-4 abbreviation of Hormones & Cancer is "HORM CANCER-US" with common acronym "hoca". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Hybrid

Hormones & Cancer

Acronym:hoca

•

Abbreviation (ISO):HORM CANCER-US

•

Identifier (ISSN):1868-8497(Print)/1868-8500(Online)

•

Publisher:Springer US

Official Website Submission Portal Compare

Clarivate Impact Factor (IF 2024)

N/A

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

Impact Factor Trend (2018–2023)

Clarivate IF trend for Hormones & Cancer

WoS Q1

Annual Impact Factor Metric

Current (2023):3

Scopus SJR & Rank

N/A

SCImago Journal Rank citation prestige weighting

Scopus / Elsevier Data

H-Index (2021)

30 papers with at least that number of citations each

WoS: SCIE / JCRQ1

Self-Citation RateN/A

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

0articles/year

13.04% Gold OA•0% Original Research

Aims & Scope

Hormones and Cancer is a unique multidisciplinary translational journal featuring basic science, pre-clinical, epidemiological, and clinical research papers. It covers all aspects of the interface of Endocrinology and Oncology. Thus, the journal covers two main areas of research: Endocrine tumors (benign & malignant tumors of hormone secreting endocrine organs) and the effects of hormones on any type of tumor. We welcome all types of studies related to these fields, but our particular attention is on translational aspects of research. In addition to basic, pre-clinical, and epidemiological studies, we encourage submission of clinical studies including those that comprise small series of tumors in rare endocrine neoplasias and/or negative or confirmatory results provided that they significantly enhance our understanding of endocrine aspects of oncology. The journal does not publish case studies.

Topics Covered (Recognized by AI)

Biology96.5%Medicine92.2%Internal medicine90.3%Genetics88.7%Cancer74.7%Endocrinology71.8%Chemistry71.2%Biochemistry69.6%Cancer research47%Pathology44.6%Breast cancer40.6%Gene39%Oncology36.3%Hormone30.9%Receptor22%Estrogen receptor20.2%

Primary Research Areas

Oncology Endocrinology & Metabolism

Official Website NLM PubMed Catalog Submission Portal

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

15 year

2023Latest

IF3

Articles / Year—

Total Citations—

2022

IF4.667

Articles / Year—

Total Citations—

2021

IF3.869

Articles / Year—

Total Citations—

2020

IF2.437

Articles / Year19

Total Citations416

2019

IF2.239

Articles / Year19

Total Citations627

Year	Impact Factor	Articles / Year	Total Citations
2023	3	—	—
2022	4.667	—	—
2021	3.869	—	—
2020	2.437	19	416
2019	2.239	19	627
2018	2.581	41	1,152
2017	—	35	895
2016	—	33	1,016
2015	—	34	686
2014	—	42	1,608
2013	—	38	1,021
2012	—	29	843
2011	—	39	1,550
2010	—	43	1,844
1996	—	20	75

SCImago & Scopus Journal Intelligence

Not indexed in SCImago / Scopus database

This journal is currently not indexed in Scopus or is an academic publication indexed exclusively in Web of Science (WoS).

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区ENDOCRINOLOGY & METABOLISM

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Hormones & Cancer (acronym: hoca, abbr: HORM CANCER-US, ISSN: 1868-8497) is a peer-reviewed international scholarly journal in the field of ONCOLOGY, published by Springer US in United States since 2010. The periodical holds tracked under Web of Science (SCIE) in quartile Q1, an H-index of 30.

The journal enforces rigorous peer evaluation with an annual output of approximately 0 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with APC fees are not specified. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.